PL3906970T3 - Parapokswirus do kondycjonowania i leczenia zakażeń koronawirusowych - Google Patents

Parapokswirus do kondycjonowania i leczenia zakażeń koronawirusowych

Info

Publication number
PL3906970T3
PL3906970T3 PL20173670.9T PL20173670T PL3906970T3 PL 3906970 T3 PL3906970 T3 PL 3906970T3 PL 20173670 T PL20173670 T PL 20173670T PL 3906970 T3 PL3906970 T3 PL 3906970T3
Authority
PL
Poland
Prior art keywords
parapoxvirus
conditioning
treatment
coronavirus infections
coronavirus
Prior art date
Application number
PL20173670.9T
Other languages
English (en)
Inventor
Daniela Paulsen
Alexander Birkmann
Peter Lischka
Tamara Pfaff
Holger Zimmermann
Original Assignee
Aicuris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co. Kg filed Critical Aicuris Gmbh & Co. Kg
Publication of PL3906970T3 publication Critical patent/PL3906970T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL20173670.9T 2020-05-08 2020-05-08 Parapokswirus do kondycjonowania i leczenia zakażeń koronawirusowych PL3906970T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20173670.9A EP3906970B1 (en) 2020-05-08 2020-05-08 Parapoxvirus for conditioning and treatment of coronavirus infections

Publications (1)

Publication Number Publication Date
PL3906970T3 true PL3906970T3 (pl) 2022-10-24

Family

ID=70680251

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20173670.9T PL3906970T3 (pl) 2020-05-08 2020-05-08 Parapokswirus do kondycjonowania i leczenia zakażeń koronawirusowych

Country Status (30)

Country Link
US (1) US20220401553A1 (pl)
EP (2) EP3906970B1 (pl)
JP (1) JP2023525269A (pl)
KR (1) KR20230008703A (pl)
CN (1) CN115003329A (pl)
AR (1) AR122044A1 (pl)
AU (1) AU2021267148A1 (pl)
BR (1) BR112022022635A2 (pl)
CA (1) CA3173998A1 (pl)
CR (1) CR20220569A (pl)
DK (1) DK3906970T3 (pl)
EC (1) ECSP22085708A (pl)
ES (1) ES2926807T3 (pl)
HR (1) HRP20221110T1 (pl)
HU (1) HUE060482T2 (pl)
IL (1) IL297983A (pl)
LT (1) LT3906970T (pl)
MX (1) MX2022013979A (pl)
PE (1) PE20230459A1 (pl)
PH (1) PH12022552990A1 (pl)
PL (1) PL3906970T3 (pl)
PT (1) PT3906970T (pl)
PY (1) PY2137280A (pl)
RS (1) RS63635B1 (pl)
SI (1) SI3906970T1 (pl)
SM (1) SMT202200390T1 (pl)
TW (1) TWI796688B (pl)
UY (1) UY39206A (pl)
WO (1) WO2021224503A1 (pl)
ZA (1) ZA202210585B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114940707B (zh) * 2022-04-19 2023-07-18 中国医学科学院病原生物学研究所 Rae1-Nup98特异性结合多肽及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1526175T4 (da) * 2003-08-18 2021-04-26 Amsterdam Inst Of Viral Genomics B V Coronavirus, nukleinsyre, protein og fremgangsmåder til generering af vaccine, lægemidler og diagnostik
CN1984666A (zh) * 2004-07-13 2007-06-20 爱库里斯股份有限两合公司 与其他抗病毒剂联合治疗hiv/aids的副痘病毒
TW201919675A (zh) * 2017-09-07 2019-06-01 德商艾庫瑞斯公司 使用羊副痘疹病毒(Parapoxvirus ovis；PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法
KR102879825B1 (ko) * 2018-09-20 2025-11-03 베링거잉겔하임베트메디카게엠베하 변형된 pedv 스파이크 단백질

Also Published As

Publication number Publication date
JP2023525269A (ja) 2023-06-15
UY39206A (es) 2021-07-30
CR20220569A (es) 2023-01-10
IL297983A (en) 2023-01-01
AU2021267148A1 (en) 2022-12-01
ES2926807T3 (es) 2022-10-28
DK3906970T3 (da) 2022-09-12
SI3906970T1 (sl) 2022-11-30
EP4146262A1 (en) 2023-03-15
ECSP22085708A (es) 2022-12-30
AR122044A1 (es) 2022-08-03
CA3173998A1 (en) 2021-11-11
PT3906970T (pt) 2022-08-23
CN115003329A (zh) 2022-09-02
SMT202200390T1 (it) 2022-11-18
ZA202210585B (en) 2023-06-28
HRP20221110T1 (hr) 2022-11-25
PH12022552990A1 (en) 2024-02-26
EP3906970B1 (en) 2022-07-06
HUE060482T2 (hu) 2023-03-28
WO2021224503A1 (en) 2021-11-11
RS63635B1 (sr) 2022-10-31
KR20230008703A (ko) 2023-01-16
MX2022013979A (es) 2023-02-09
TW202207980A (zh) 2022-03-01
BR112022022635A2 (pt) 2023-05-02
LT3906970T (lt) 2022-10-10
PY2137280A (es) 2022-01-27
PE20230459A1 (es) 2023-03-10
EP3906970A1 (en) 2021-11-10
US20220401553A1 (en) 2022-12-22
TWI796688B (zh) 2023-03-21

Similar Documents

Publication Publication Date Title
SI4204421T1 (sl) Spojine in postopki za zdravljenje virusnih okužb
IL315102A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
EP4186496A4 (en) USE OF CANNABIDIOL IN THE TREATMENT OF CORONAVIRUS INFECTIONS
IL277315B (en) Method and preparations for treating the corona virus infection
EP4135719A4 (en) TREATMENT OF CORONAVIRUS INFECTIONS
GB202416189D0 (en) Methods for the prophylaxis and treatment of Covid and Covid-19
IL288861A (en) A drug and its use for the treatment of bacterial infections associated with biofilm
ZA202210585B (en) Parapoxvirus for conditioning for and treatment of coronavirus infections
GB202013874D0 (en) Treatment and prevention of viral infections
GB2595513B (en) Treatment of infections
IL319307A (en) Compositions and methods for preventing and treating orthopoxvirus infections
GB202103578D0 (en) Prevention and treatment of infections including those caused by coronavirus
HK40084667A (en) Parapoxvirus for conditioning for and treatment of coronavirus infections
IL307872A (en) New compositions and methods for the treatment of corona virus infections
IL312285A (en) L-BHDU drugs and treatment methods for viral infections
IL286994A (en) A method for the treatment and prevention of bone and joint infections
IL276627A (en) Compositions for diagnosis and treatment of coronavirus infections
ZA202005856B (en) Treatment of infections
AU2021902534A0 (en) Improved treatment for COVID and other pathogens
GB202005126D0 (en) Treatment and prevention of viral infections
HK40087039A (en) Methods of treating coronavirus infections
IL309452A (en) Preparations for the treatment of viral infections and methods thereof
GB202013389D0 (en) Diagnosis and treatment of burkholderia infections
GB202014412D0 (en) Treatment of coronavirus
IL315712A (en) Methods for treating viral infections of influenza and chicken pox